Click here to see a list of our past events.
The Empower Conference 2023 Pitch Competition celebrates women academic entrepreneurship and all founders and researchers who have or are planning to commercialize university-developed intellectual property across all disciplines including technology, physical sciences, life sciences and social sciences.
Applicants will compete for over $150K of cash and in-kind prizes, including a first-place cash prize of $100K and a $10K bundle of in-kind legal and advisory services. The semi-finalists and finalists in the selection process will also receive expert mentoring advice and the opportunity to meet with several VC firms. Application is due Monday, March 6, 2023. Apply here.
This program is designed to generate therapeutic antibodies or proteins against validated drug targets, with the goal of advancing these to pre-clinical development. Leveraging support from our industry partner, Takeda Pharmaceuticals Co., Tri-I TDI will provide resources to discovery and engineer therapeutic antibodies and proteins that will be used for in vitro and in vivo proof-of-concept studies in the laboratory of the principal investigator (PI). Outcomes can include monospecific or bispecific antibodies, antibody-drug conjugates, and protein therapeutics.
Principal Investigators, who are full-time employees of Weill Cornell Medicine, are eligible to apply. Letters of Intent due March 3, 2023.
Log into your VPN to access the application page for more details and application process: https://intranet.tritdi.org/applications/therapeutic-antibodies/.
The 2023 Health Hackathon is an in-person interdisciplinary event bringing together students from across degrees, majors, and schools! On Friday evening, teams comprised of medical, business, engineering, and design students, form and begin to create solutions to needs in human health & wellness. On Saturday, mentors provide feedback and guidance to teams. On Sunday, the hackathon culminates in a project showcase to an audience of peers, mentors, and sponsors.
A panel of judges select winners and award $5,000 to winning teams.
Point-of-care devices, medical devices, health-tech, hardware, software the choice is yours on the types of challenges to tackle.
This is the third installment in Osage University Partners’ series on Funding and Equity for University Startups. Marc Singer and Matt Cohen of OUP will review Valuation and Term Sheets:
- How valuation works
- Valuation scenarios
- How OUP does comp analyses for companies
- Basics of a startup investment term sheet
- How term sheet negotiations work
- Finalizing the term sheet and the financing of the company
The intended audience for this webinar is university startup founders, including future founders and academic technology commercialization groups. You may submit your questions ahead of time on the registration page or by emailing kmangels@oup.vc.
This exciting program is for Principal Investigators who are employed full-time by Weill Cornell Medicine. Tri-I TDI partners with Takeda Pharmaceuticals to advance early-stage projects, that have the potential to benefit patients, to proof-of-concept studies.
The program’s objective is to develop novel compounds that elucidate fundamental physiologic and pathological processes, improve efficiency in drug development, create intellectual property that can be further developed by industry collaborators, and translate basic research into clinical application.
Only small molecule chemical compounds will be considered, which excludes antibody, protein and any other biologic therapeutics.
Log into your VPN to access the application page for more details and application process: https://intranet.tritdi.org/applications/small-molecules/.
